Attributes | Values |
---|
http://linked.open...nk/propertySource
| - ALOGPS
- ChemAxon
- Stenlake, J.B., Waigh, R.D., Dewar,G.H., Urwin, J. and Dhar, N.C.; U.S. Patent 4,179,507 December 18,1979; assigned to BurroughsWellcome Company.
|
http://linked.open...ank/propertyValue
| - 2
- 0
- -4.5
- 142.116
- 7.48
- 161.068807845
- 59.22
- 4-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,3-dihydropurin-7-yl}butoxyphosphonic acid
- 385.211389755
- 65.33
- 85-90
- C5H9NO4S
- InChIKey=XADCWKSMHQPTGH-OFBLZTNGSA-N
- furazabol
- 2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icosa-4,7-dien-17-ol
- 3-cyclohexyl-1-[2-(morpholin-4-yl)-2-oxoethyl]-2-phenyl-1H-indole-6-carboxylic acid
|
is http://linked.open...ugbank/IUPAC-Name
of | |
is http://linked.open...Molecular-Formula
of | |
is http://linked.open.../Molecular-Weight
of | |
is http://linked.open...noisotopic-Weight
of | |
is http://linked.open...ogy/drugbank/logS
of | |
is http://linked.open...-Bond-Donor-Count
of | |
is http://linked.open...drugbank/InChIKey
of | |
is http://linked.open...urface-Area--PSA-
of | |
is http://linked.open...bank/Refractivity
of | |
is http://linked.open...ank/Melting-Point
of | |
is http://linked.open...bank/Rule-of-Five
of | |
is http://linked.open...tional-IUPAC-Name
of | - Furazabol
- 4-{2,6,8-Trioxo-9-[(2s,3r,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate
|
is http://linked.open...-strongest-basic-
of | |